A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the safety and efficacy of topiramate in the treatment of obese, type 2 diabetic patients on a controlled diet.
Phase of Trial: Phase III
Latest Information Update: 23 Jun 2009
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 23 Jun 2009 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 23 Jun 2009 Actual end date (1 May 2002) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History